In this webinar, two experts from Lonza will look at issues around drug solubility, and how bioavailability can be improved. Compounds that are poorly soluble in water are still prevalent in the drug development pipeline, and technologies such as amorphous solid dispersion (ASD) can be used to improve their bioavailability.
This enables effective drug products to be made as tablets or capsules.
You will find out how bioavailability enhancement techniques can contribute to the creation of successful drug products, and how Lonza’s Capsule Applications Services lab can also help by developing innovative capsules to tailor drug delivery and ensure the ASDs remain stable in the long term.